Conformational Domino Effect in Saccharides
(d, J ) 8.5 Hz, 2H), 7.54 (t, J ) 8.5 Hz, 2H), 7.52 (t, J ) 8.5 Hz,
2H), 5.36 (t, J ) 9.3 Hz, H-4′), 5.25 (d, J ) 3.5 Hz, H-1), 5.05 (t,
J ) 8.5 Hz, H-2′), 4.59 (d, J ) 8.0 Hz, H-1′), 4.49 (m, H-2,
H-6′proS), 4.36 (dd, J ) 4.5, 12.1 H-6′proR), 4.00 (m, H-3′, H-6proS),
3.93 (t, J ) 8.9 Hz, H-3), 3.87 (m, H-5, H-5′), 3.75 (dd, J ) 4.8,
10.4 Hz, H-6proR), 3.44 (dt, J ) 3.2, 9.0, H-4), 2.34 (d, J ) 3.2 Hz,
1H), 2.10 (s, 3H), 2.05 (s, 3H), 1.17 (s, 9H), 0.87 (s, 9H), 0.71 (s,
+43.4 (c 0.32, CHCl3); MS (FAB) 531, 529, 527 (0.8, 3, 1,
[C20H17Br2O7]), 307 (9, [C12H19O9]), 185, 183 (9.60, 11, [BrBz]),
154 (100); 1H NMR (δ, DMSO) 7.89 (d, J ) 8.6 Hz, 2H), 7.86 (d,
J ) 8.6 Hz, 2H), 7.76 (d, J ) 8.6 Hz, 2H), 7.72 (d, J ) 8.6 Hz,
2H), 5.53 (d, J ) 5.3 Hz, 1H), 5.30 (d, J ) 4.7 Hz, 1H), 4.99 (d,
J ) 7.0 Hz, 1H), 4.98 (t, J ) 9.6 Hz, H-4′), 4.86 (br s, 1H), 4.73
(d, J ) 3.7 Hz, H-1), 4.64 (d, J ) 5.6 Hz, 1H), 4.46 (d, J ) 7.8
Hz, H-1′), 4.40 (dd, J ) 2.8, 12.0 Hz, H-6′proS), 4.28 (dd, J ) 5.6,
10.8 Hz, H-6′proR), 3.98 (m, H-5′), 3.98 (d, J ) 10.1 Hz, H-6proS),
3.80 (m, H-5), 3.69 (dd, J ) 6.4, 11.0 Hz, H-6proR), 3.64 (m, H-3′),
3.42 (br t, J ) 7.5 Hz, H-3), 3.26-3.19 (m, H-2, H-2′, 1H), 3.12
(m, H-4), 2.43 (m, 1H), 2.25 (br d, J ) 12.2 Hz, 1H), 1.57 (m,
2H), 1.35 (m, 2H), 1.14 (m, 1H), 0.95 (m, 2H), 0.89 (d, J ) 6.5
Hz, 3H), 0.83 (d, J ) 7.0 Hz, 3H), 0.78 (m, 1H), 0.73 (d, J ) 6.9
Hz, 3H); 13C NMR (δ, DMSO) 165.8 (s), 165.5 (s), 132.7-128.4,
104.8 (d, C-1′), 101.6 (d, C-1), 81.3* (d), 74.6* (d, C-2), 74.6* (d,
C-3′), 73.9 (d, C-3), 73.4 (d, C-4′), 73.2* (d, C-2′), 72.5 (d, C-5),
71.6 (d, C-5′), 70.3 (d, C-4), 70.8 (t, C-6), 64.7 (t, C-6′), 49.4 (d),
43.4 (t), 34.9 (t), 32.1 (d), 24.9 (d), 23.5 (t), 23.3 (q), 21.9 (q),
17.0 (q); UV (EtOH) λmax 245 nm; CD (EtOH) λ (∆ε) 251 (12.0),
234 nm (-3.1). Anal. Calcd for C36H46Br2O13: C, 51.08; H, 5.48.
Found: C, 51.07; H, 5.64.
9H), 0.11 (s, 3H), 0.09 (s, 3H), -0.01 (s, 3H), -0.20 (s, 3H); 13
C
NMR (δ, CDCl3) 170.4 (s), 169.2 (s), 165.5 (s), 164.3 (s),
131.9-128.4, 101.1 (d, C-1′), 90.4 (d, C-1), 75.2 (s), 74.1 (d, C-2),
73.5 (d, C-2′), 73.1 (d, C-3′), 72.4 (d, C-3), 72.2 (d, C-4′), 72.1 (d,
C-4), 71.9 (d, C-5), 69.5 (d, C-5′), 68.5 (t, C-6), 63.4 (t, C-6′),
29.7 (q), 29.3 (q), 28.4 (3q), 25.7 (3q), 25.4 (3q), 21.3 (q), 21.0
(q), 18.1 (s), 17.7 (s), -4.5 (4q). Anal. Calcd for C46H68Br2O15Si2:
C, 51.30; H, 6.36. Found: C, 51.42; H, 6.53.
Methyl 6-O-[4,6-Bis-O-(4-bromobenzoyl)-ꢀ-D-glucopyrano-
syl]-r-D-glucopyranoside (11r). Following the general procedure
for desilylation and deacetylation, 35 mg (0.08 mmol) of compound
7r yielded 17.3 mg of compound 11r (63%): TLC Rf ) 0.17
(CH2Cl2/MeOH, 9:1); mp ) 160.2-161.5 °C; [R]25 ) +74.6 (c
D
0.39, CHCl3); MS (FAB) 745 (0.4, [M + Na]+), 531, 529, 527 (3,
7, 4, [C20H17Br2O7]), 307 (17, [C12H19O9]), 185, 183 (30, 29,
1
[BrBz]), 154 (100); H NMR (δ, DMSO) 7.89 (d, J ) 8.5 Hz,
Methyl 2,3,4-Tri-O-acetyl-6-O-[2,3-di-O-acetyl-4,6-bis-O-(4-
bromobenzoyl)-ꢀ-D-glucopyranosyl]-r-D-glucopyranoside (14r).
Compound 11r (65 mg, 0.09 mmol) was dissolved in 1 mL of a
1:1 solution of dry pyridine/acetic anhydride. Excess solvent was
removed under reduced pressure to give, after column chromatog-
raphy (n-hexane/EtOAc, 8:2), compound 14r (66.0 mg) in 79%
yield: TLC Rf ) 0.36 (n-hexane/EtOAc, 1:1); mp ) 230.5-232.9
2H), 7.85 (d, J ) 8.5 Hz, 2H), 7.75 (d, J ) 8.6 Hz, 2H), 7.73 (d,
J ) 8.5 Hz, 2H), 5.49 (d, J ) 5.6 Hz, 1H), 5.38 (d, J ) 4.9 Hz,
1H), 5.05 (d, J ) 6.4 Hz, 1H), 5.02 (t, J ) 9.6 Hz, H-4′), 4.88 (br
s, 1H), 4.76 (d, J ) 6.3 Hz, 1H), 4.55 (d, J ) 3.6 Hz, H-1), 4.51
(d, J ) 7.8 Hz, H-1′), 4.39 (dd, J ) 3.0, 12.0 Hz, H-6′proS), 4.32
(dd, J ) 4.8, 12.0 Hz, H-6′proR), 4.00 (br d, J ) 11.0, H-6proS), 3.96
(m, H5′), 3.68 (dd, J ) 6.8, 11.3 Hz, H-6proR), 3.62 (m, H5, H3′),
3.42 (m, H-3), 3.30 (s, 3H), 3.22 (m, H-2, H-2′), 3.11 (m, H-4);
13C NMR (δ, DMSO) 165.7 (s), 165.4 (s), 132.8-128.4, 104.6 (d,
C-1′), 100.6 (d, C-1), 74.6* (d, C-3′), 74.5* (d, C-2′), 74.2 (d, C-3),
73.2 (d, C-4′), 72.8* (d, C-2), 72.2* (d, C-5), 71.6 (d, C-5′), 71.3
(d, C-4), 70.3 (t, C-6), 64.5 (t, C-6′), 55.4 (q); UV (EtOH) λmax
245 nm; CD (EtOH) λ (∆ε) 251 (11.8), 234 nm (-3.7). Anal. Calcd
for C27H30Br2O13: C, 44.90; H, 4.19. Found: C, 44.91; H, 4.54.
(+)-Menthyl 6-O-[4,6-Bis-O-(4-bromobenzoyl)-ꢀ-D-glucopy-
ranosyl]-r-D-glucopyranoside (12r). Following the general pro-
cedure for desilylation and deacetylation, 45.5 mg (0.04 mmol) of
compound 8r yielded 27.3 mg of compound 12r (81%): TLC Rf
°C dec; [R]25 ) +46.7 (c 1.63, CHCl3); MS (FAB) 933 (0.6,
D
[M]+), 615, 613, 611 (9, 17, 8, [C24H21Br2O9]), 307 (25,
1
[C12H19O9]), 185, 183 (21, 22, [BrBz]), 154 (100); H NMR (δ,
CDCl3) 7.81 (d, J ) 8.5 Hz, 2H), 7.77 (d, J ) 8.5 Hz, 2H), 7.54
(d, J ) 8.5 Hz, 4H), 5.45 (t, J ) 9.6 Hz, H-4′), 5.42 (t, J ) 9.4 Hz,
H-3′), 5.39 (t, J ) 9.4 Hz, H-3), 5.10 (t, J ) 8.0 Hz, H-2′), 4.92
(d, J ) 3.5 Hz, H-1), 4.91 (t, J ) 9.4 Hz, H-4), 4.84 (dd, J ) 3.5,
10.2 Hz, H-2), 4.66 (d, J ) 7.9 Hz, H-1′), 4.53 (dd, J ) 3.3, 12.1
Hz, H-6′proS), 4.39 (dd, J ) 4.8, 12.1 Hz, H-6′proR), 3.97-3.92 (H-
5′, H-5, H-6proS), 3.57 (dd, J ) 6.5, 11.1 Hz, H-6proR), 3.38 (s, 3H),
2.07 (s, 6H), 1.99 (s, 6H), 1.90 (s, 3H); 13C NMR (δ, CDCl3) 170.1
(2s), 170.0 (s), 169.6 (s), 169.3 (s), 165.3 (s), 164.4 (s), 132.0-127.6,
101.1 (d, C-1′), 96.5 (d, C-1), 72.3 (d, C-3), 71.8 (d, C-5′), 71.1
(d, C-2′), 70.9 (d, C-2), 70.1 (d, C-4′), 69.9 (d, C-3′), 69.0 (d, C-4),
68.2 (d, C-5), 68.2 (t, C-6), 63.1 (t, C-6′), 55.3 (q), 20.6 (4q), 20.5
(q); UV (CH3CN) λmax 245 nm; CD (CH3CN) λ (∆ε) 251 (15.0),
234 nm (-7.0). Anal. Calcd for C37H40Br2O18: C, 47.66; H, 4.32.
Found: C, 47.67; H, 4.49.
) 0.37 (CH2Cl2/MeOH, 9:1); mp ) 158.3-159.7 °C; [R]25
)
D
+7.5 (c 0.43, CHCl3); MS (FAB) 871, 869, 867 (1, 1, 1, [M +
Na]+), 531, 529, 527 (5, 10, 5, [C20H17Br2O7]), 307 (26,
1
[C12H19O9]), 185, 183 (16, 17, [BrBz]), 154 (100); H NMR (δ,
DMSO) 7.89 (d, J ) 8.5 Hz, 2H), 7.84 (d, J ) 8.6 Hz, 2H), 7.75
(d, J ) 8.6 Hz, 2H), 7.71 (d, J ) 8.4 Hz, 2H), 5.50 (d, J ) 5.7 Hz,
1H), 5.28 (d, J ) 4.9 Hz, 1H), 5.01 (d, J ) 5.6 Hz, 1H), 5.00 (t,
J ) 9.6 Hz, H-4′), 4.86 (d, J ) 3.8 Hz, H-1), 4.82 (d, J ) 4.4 Hz,
1H), 4.47 (d, J ) 6.8 Hz, 1H), 4.45 (d, J ) 8.1 Hz, H-1′), 4.35 (d,
J ) 4.0 Hz, H-6′proS, H-6′proR), 3.96 (m, H-5′), 3.92 (d, J ) 10.0
Hz, H-6proS), 3.71 (dd, J ) 4.6, 10.8 Hz, H-6proR), 3.64-3.59 (m,
H-5, H-3′), 3.42-3.32 (m, H-3), 3.30 (m, H-4), 3.25-3.20 (m, H-2,
H-2′), 2.22 (m, 1H), 2.10 (br d, J ) 12.2 Hz, 1H), 1.61 (m, 2H),
1.33 (m, 1H), 1.21 (m, 1H), 1.05 (m, 1H), 0.91 (d, J ) 6.4 Hz,
3H), 0.87 (d, J ) 6.9 Hz, 3H), 0.69 (d, J ) 6.8 Hz, 3H); 13C NMR
(δ, DMSO) 165.6 (s), 165.4 (s), 132.7-128.4, 104.2 (d, C-1′), 95.7
(d, C-1), 75.3* (d, C-3), 74.7* (d, C-5), 74.5* (d, C-2′), 74.0* (d),
73.3 (d, C-4′), 72.5* (d, C-2), 72.5* (d, C-3′), 71.5 (d, C-5′), 70.5*
(d, C-4), 69.3 (t, C-6), 64.6 (t, C-6′), 48.6 (d), 40.4 (t), 35.0 (t),
31.7 (d), 25.6 (d), 23.3 (t), 23.2 (q), 22.1 (q), 16.3 (q); UV (EtOH)
(+)-Menthyl 2,3,4-Tri-O-acetyl-6-O-[2,3-di-O-acetyl-4,6-bis-
O-(4-bromobenzoyl)-ꢀ-D-glucopyranosyl]-r-D-glucopyrano-
side (15r). Compound 12r (15 mg, 0.02 mmol) was dissolved in
1 mL of a 1:1 solution of dry pyridine/acetic anhydride. Excess
solvent was removed under reduced pressure to give, after column
chromatography (n-hexane/EtOAc, 8:2), compound 15r (14.5 mg,
0.05 mmol) in 76% yield: TLC Rf ) 0.35 (n-hexane/EtOAc, 6:4);
mp ) 236.3-238.7 °C (dec); [R]25 ) +77.6 (c 1.02, CHCl3);
D
MS (FAB) 1077 (0.4, [M + Na]+), 903, 901, 899 (5, 10, 4,
[C37H44Br2O17]), 615, 613, 611 (43, 83, 42, [C24H21Br2O9]), 185,
1
183 (97, 100, [BrBz]); H NMR (δ, CDCl3) 7.80 (d, J ) 8.6 Hz,
2H), 7.76 (d, J ) 8.6 Hz, 2H), 7.53 (d, J ) 8.6 Hz, 2H), 7.50 (d,
J ) 8.6 Hz, 2H), 5.45-5.35 (m, H-4′, H-3, H-3′), 5.24 (d, J ) 3.9
Hz, H-1), 5.08 (dd, J ) 7.9, 9.4 Hz, H-2′), 5.01 (t, J ) 9.8 Hz,
H-4), 4.78 (dd, J ) 3.9, 10.4 Hz, H-2), 4.59 (d, J ) 7.9 Hz, H-1′),
4.50 (dd, J ) 3.5, 12.1 Hz, H-6′proS), 4.40 (dd, J ) 4.9, 12.1 Hz,
H-6′proR), 4.01-3.90 (m, H-5′, H-6proS, H-5), 3.50 (dd, J ) 4.2,
10.5 Hz, H-6proR), 3.38 (dt, J ) 3.9, 10.5 Hz, 1H), 2.18 (m, 1H),
2.09 (s, 3H), 2.03 (s, 3H), 2.02 (s, 3H), 1.99 (s, 3H), 1.90 (s, 3H),
1.83 (m, 1H), 1.70 (m, 2H), 1.31 (m, 2H), 0.92 (d, J ) 6.9 Hz,
3H), 0.87 (d, J ) 6.5 Hz, 3H), 0.70 (d, J ) 6.9 Hz, 3H); 13C NMR
(δ, CDCl3) 170.1 (3s), 169.5 (s), 169.4 (s), 165.3 (s), 164.4 (s),
λ
max 245 nm; CD (EtOH) λ (∆ε) 251 (11.1), 234 nm (-3.1). Anal.
Calcd for C36H46Br2O13: C, 51.08; H, 5.48. Found: C, 51.08; H,
5.64.
(-)-Menthyl 6-O-[4,6-Bis-O-(4-bromobenzoyl)-ꢀ-D-glucopy-
ranosyl]-r-D-glucopyranoside (13r). Following the general pro-
cedure for desilylation and deacetylation, 33.0 mg (0.03 mmol) of
compound 9r yielded 21.0 mg of compound 13r (88% yield): TLC
Rf ) 0.35 (CH2Cl2/MeOH, 9:1); mp ) 157.7-158.9 °C; [R]25
)
D
J. Org. Chem. Vol. 73, No. 18, 2008 7277